Full Year 2023 Investor Presentation

119 Investor presentation Full year 2023 Diabetes market share and market growth in EMEA 75% 50% 25% 0% Diabetes market growth and Novo Nordisk market share Nov DKK billion 20% 17% Diabetes market size and growth ~10% 5 109 -5 15% 49% EMEA 11 120 10% 10% 31% 5% ~17% 31% 29% 0% Nov Nov NN Company A Others Nov 2023 2022 2023 Novo Nordisk Competitors 2020 -NN market share -Market growth (right axis) EMEA: Europe, Middle East and Africa; NN: Novo Nordisk NN share of growth NN growth (right axis) Note: Due to contractual obligations competitor names are not disclosed. Company A represents an actual company; Market values are based on the list prices Source: IQVIA, Nov 2023, Value, MAT

View entire presentation